Straumann
Price
Price
CHART BY
Historical dividends and forecast
Straumann has so far distributed $0.932 in 2024. The next dividend will be paid on 18.04.2025
CHART BY
Frequently asked questions
What is Straumann's market capitalization?
What is Straumann's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Straumann?
What are the analyst ratings and target price for Straumann's stock?
What is Straumann's revenue over the trailing twelve months?
What is the EBITDA for Straumann?
What is the free cash flow of Straumann?
How many employees does Straumann have, and what sector and industry does it belong to?
What is the free float of Straumann's shares?
Financials
- Market Cap
- $20.32B
- EPS (TTM)
- $1.901
- Free Float
- 107.24M
- P/E ratio (TTM)
- 67.05
- Revenue (TTM)
- $2.76B
- EBITDA (TTM)
- $647.66M
- Free Cashflow (TTM)
- $411.89M
Pricing
- 1D span
- $124.66$128.15
- 52W span
- $118.29$172.61
Analyst Ratings
The price target is $152.24 and the stock is covered by 21 analysts.
Buy
9
Hold
6
Sell
6
Information
Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. It operates through the following segments: Sales Western Europe, Sales Central Eastern Europe, Middle East and Africa (CEEMEA), Sales North America (NAM), Sales Asia Pacific (APAC), Sales Latin America (LATAM), and Operations. The Sales Western Europe segment comprises Group’s distribution businesses in Scandinavia, the UK, France, the Benelux countries, Iberia and Italy; implant-borne prosthetics business of Createch, as well as Anthogyr manufacturing plants, a French company that develops and manufactures dental implant systems and CADCAM solutions. The Sales CEEMEA segment comprises the Group's distribution businesses mainly in Germany, Switzerland, Austria, Hungary, the Czech Republic, Russia, Turkey, Croatia, Jordan and South Africa, as well as the business with European, African and Middle Eastern distributors. The Sales NAM segment comprises ClearCorrect’s clear-aligner business and its associated development and production activities. The Sales APAC segment comprises Group’s distribution businesses in the Asia pacific region, as well as the business with Asian distributors. The Sales LATAM segment comprises distribution and Instradent businesses in Middle and South America, and Latin America. The Operations segment manufactures plants, implants, and biomaterials. The company was founded by Reinhard Straumann in 1954 and is headquartered in Basel, Switzerland.
- Employees
- 11,109
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- CH1175448666
- Primary Ticker
- STMN